We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current 39K market cap is 11.29M. The company's latest EPS is EUR -1.1537 and P/E is -0.39.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 40.48M | 48.78M | 127.67M | 188.57M | 66.93M |
| Operating Income | -10.61M | -18.14M | -16.67M | -44.53M | -29.16M |
| Net Income | -10.96M | -20.86M | -21.99M | -46.25M | -31.84M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 76.67M | 117.51M | 149.92M | 91.14M | 92.81M |
| Total Liabilities | 50.15M | 58.59M | 84.99M | 63.88M | 85.4M |
| Total Equity | 26.52M | 58.92M | 64.93M | 27.26M | 7.41M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -4.58M | -7.78M | 8.46M | -21.74M | -26.49M |
| Investing | -8.69M | 14.18M | -16.15M | -5.36M | -733k |
| Financing | 19.34M | 25.47M | 14.84M | -3.2M | 46.32M |
| Market Cap | 11.29M |
| Price to Earnings Ratio | -0.39 |
| Price to Sales Ratio | 0.19 |
| Price to Cash Ratio | 0.35 |
| Price to Book Ratio | 1.68 |
| Dividend Yield | - |
| Shares Outstanding | 27.6M |
| Average Volume (1 week) | 1.65k |
| Average Volume (1 Month) | 4.35k |
| 52 Week Change | -58.01% |
| 52 Week High | 1.445 |
| 52 Week Low | 0.3895 |
| Spread (Intraday) | 0.03 (7.13%) |
| Company Name | Centogene NV |
| Address |
am strande 7 rostock 18055 |
| Website | https://www.centogene.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
